Partial
Partially Aligned
Patient Risk:
Medium
Summary
Several non-prescribing claims about branding/availability and 0.1% strength are not supported by the provided FDA label excerpts. The label excerpt does support that DIFFERIN Gel is adapalene topical gel (0.3%) for acne in patients ≥12 years, but the response does not address that. Net result is partial alignment due to unsupported brand/market-strength statements.
Category Scores
Accurate Statements
Unsupported Statements
Adapalene gel is most commonly sold under the brand name Differin Gel.
Provided label excerpts do not discuss market prevalence or branding frequency.
In the U.S., adapalene topical products are frequently available as generics as well as branded formulations.
Provided label excerpts do not address generic availability or market distribution.
Differin is the best-known brand name for adapalene.
Provided label excerpts do not provide statements about brand recognition.
Specific product/strength brand availability of adapalene can vary by pharmacy and country.
Provided label excerpts do not describe pharmacy/country-specific availability.
Differin Gel is commonly sold in 0.1% strength for acne treatment.
Provided label excerpts describe DIFFERIN Gel as adapalene 0.3% (3 mg/g). No label support is provided for a 0.1% DIFFERIN Gel product.
Other strengths or formulations of Differin Gel may exist depending on the market.
Provided label excerpts do not state that DIFFERIN Gel is available in other strengths or formulations.
Contradictions
Low
AI Statement
Differin Gel is commonly sold in 0.1% strength for acne treatment.
Label Reference
Label DESCRIPTION: “DIFFERIN Gel contains adapalene 0.3% (3 mg/g)”
Important Omissions
FDA-approved indication and age requirement (acne vulgaris in patients 12 years of age and older).
Importance:
Moderate
Correct labeled strength/formulation for DIFFERIN Gel (adapalene 0.3% topical aqueous gel) and labeled dosing instructions (apply thin film once daily in the evening; avoid eyes/lips/mucous membranes; minimize sun exposure; re-evaluate if no results after 12 weeks).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
The response states DIFFERIN Gel is commonly sold in 0.1% strength, while the provided label excerpts specify DIFFERIN Gel is adapalene 0.3%. This mismatch could plausibly lead to confusion about the labeled product strength. Other statements are largely market/branding claims without direct prescribing detail.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Incorrect/unsupported strength claim for DIFFERIN Gel (0.1% stated vs 0.3% in label excerpts) and multiple branding/availability statements not addressed by the provided label.
Suggested Improvement
Restrict claims to information explicitly supported by the provided label excerpts (e.g., DIFFERIN Gel contains adapalene 0.3% topical aqueous gel and is indicated for acne vulgaris in patients ≥12 years), and omit market prevalence/brand recognition/availability statements that are not present in the label.